Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On January 28, 2009, Bioject Medical Technologies Inc. ("Bioject") entered into a letter agreement (the "Agreement") with each of Mr. Ralph Makar, Bioject's President and CEO, Ms. Christine M. Farrell, Bioject's Vice President of Finance and member of the Executive Committee, and Mr. Richard R. Stout, M.D., Bioject's Executive Vice President and Chief Medical Officer and member of the Executive Committee, pursuant to which each such executive voluntarily agreed to reduce his or her monthly base salary by 20%, commencing February 1, 2009, notwithstanding any provision of any employment agreement between Bioject and such executive to the contrary. The base salary of each executive immediately prior to such reduction shall continue to be such executive's base salary for all other purposes under executive's employment agreement or under Bioject's personnel policies. Bioject will revert to paying each executive his or her base salary immediately prior to the foregoing reduction upon the written request of such executive.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

The following exhibit is filed herewith and this list is intended to constitute the exhibit index:

10.1 Form of letter agreement dated January 28, 2009.

---